Related Experiment Video
Updated: May 10, 2026

Quantifying Tissue-Specific Proteostatic Decline in Caenorhabditis elegans
Published on: September 7, 2021
REGγ deficiency promotes premature aging via the casein kinase 1 pathway
Lei Li1, Dengpan Zhao, Haibin Wei
1Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, East China Normal University, Shanghai 200241, China.
Abstract:
Our recent studies suggest a role for the proteasome activator REG (11S regulatory particles, 28-kDa proteasome activator)γ in the regulation of tumor protein 53 (p53). However, the molecular details and in vivo biological significance of REGγ-p53 interplay remain elusive. Here, we demonstrate that REGγ-deficient mice develop premature aging phenotypes that are associated with abnormal accumulation of casein kinase (CK) 1δ and p53. Antibody array analysis led us to identify CK1δ as a direct target of REGγ. Silencing CK1δ or inhibition of CK1δ activity prevented decay of murine double minute (Mdm)2. Interestingly, a massive increase of p53 in REGγ(-/-) tissues is associated with reduced Mdm2 protein levels despite that Mdm2 transcription is enhanced. Allelic p53 haplodeficiency in REGγ-deficient mice attenuated premature aging features. Furthermore, introducing exogenous Mdm2 to REGγ(-/-) MEFs significantly rescues the phenotype of cellular senescence, thereby establishing a REGγ-CK1-Mdm2-p53 regulatory pathway. Given the conflicting evidence regarding the "antiaging" and "proaging" effects of p53, our results indicate a key role for CK1δ-Mdm2-p53 regulation in the cellular aging process. These findings reveal a unique model that mimics acquired aging in mammals and indicates that modulating the activity of the REGγ-proteasome may be an approach for intervention in aging-associated disorders.
Insights
The proteasome activator REGγ is crucial for preventing premature aging by regulating casein kinase 1δ (CK1δ), Mdm2, and tumor protein 53 (p53) levels. This discovery offers new insights into aging and potential therapeutic targets.
Area of Science:
- Molecular Biology
- Aging Research
- Proteostasis
Background:
- The proteasome activator REGγ (11S regulatory particles, 28-kDa proteasome activator) is implicated in regulating tumor protein 53 (p53).
- The precise molecular mechanisms and in vivo significance of the REGγ-p53 interaction are not fully understood.
Purpose of the Study:
- To elucidate the molecular interplay between REGγ and p53 in vivo.
- To investigate the role of REGγ in aging and identify key regulatory pathways involved.
Main Methods:
- Generation and analysis of REGγ-deficient mice.
- Antibody array analysis to identify REGγ targets.
- Gene silencing and activity inhibition of CK1δ.
- Assessment of Mdm2 and p53 protein levels and transcription.
- Cellular senescence assays in mouse embryonic fibroblasts (MEFs).
Main Results:
- REGγ-deficient mice exhibit premature aging phenotypes linked to elevated CK1δ and p53.
- CK1δ is identified as a direct target of REGγ; its inhibition stabilizes Mdm2.
- REGγ deficiency leads to reduced Mdm2 protein despite enhanced transcription, correlating with increased p53.
- Restoration of Mdm2 in REGγ-deficient MEFs rescues cellular senescence.
- p53 haplodeficiency attenuates premature aging in REGγ-deficient mice.
Conclusions:
- A novel regulatory pathway (REGγ-CK1δ-Mdm2-p53) governing cellular aging is established.
- This pathway highlights the critical role of CK1δ-Mdm2-p53 in the aging process.
- Modulating REGγ-proteasome activity may offer a therapeutic strategy for aging-associated disorders.
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
GPCRs Regulate Adenylyl Cylase Activity
Two...
GPCR Desensitization
Replicative Cell Senescence
Replicative Cell Senescence
